ORPHA:1302
Cryptogenic organizing pneumonia
Also known as: BOOP · Bronchiolitis obliterans organizing pneumonia · COP
Publications
12,177
Trials
5
Interventional, condition-specific
Researchers
1,237
Distinct authors in sample
Gene link
—
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
A rare form of interstitial pneumonia characterized pathologically by organizing pneumonia (OP) that presents with nonspecific flu-like symptoms, as well as cough and dyspnea, and where no etiological agent is found.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0015264
- MeSH:D018549
- UMLS:C0242770
- NCIT:C62586
Additional Mondo synonyms (5)
Organizing Pneumonia · bronchiolitis obliterans organizing pneumonia · cryptogenic organizing pneumonitis · organising pneumonia · organizing pneumonia
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
12,177 matched papers (8,170 in last 10 years) Source
- Phenotype characterisedPresent
30 HPO annotations (e.g. Fever; Increased total leukocyte count; Anorexia) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
5 matched on ClinicalTrials.gov
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
30
Associated phenotypes · MONDO:0015264
- Fever
- Increased total leukocyte count
- Anorexia
- Weight loss
- Wheezing
Showing 5 of 30 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
CTD chemicals (MyDisease.info)
2 associated chemicals. Therapeutic evidence is listed first when present — not a treatment recommendation.
- Steroids · therapeutic
- Phenytoin · marker/mechanism
Literature
Is anyone studying this?
12,177
12,177 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
12,177 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
8,170 in the last 10 years · low confidence
Phrase hits: 12,177 · MeSH hits: 0
Who's working on it?
1,237
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Inoue Y4 papers · 2026
Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Papers in Europe PMC - 02Li X4 papers · 2026
Department of Pediatrics The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital jinan Shandong China.
Papers in Europe PMC - 03Liu Y4 papers · 2026
Department of Respirology, Hebei children's Hospital, Hebei Clinical Medicine Research Center for Children's Health and Diseases, Shijiazhuang, China.
Papers in Europe PMC - 04Suda T4 papers · 2025
Second Department of Internal Medicine, Hamamatsu University School of Medicine, Japan.
Papers in Europe PMC - 05Toyoshima M4 papers · 2025
Department of Respiratory Medicine, Hamamatsu Rosai Hospital, Japan.
Papers in Europe PMC - 06Wang Y4 papers · 2025
Department of Respirology, Hebei children's Hospital, Hebei Clinical Medicine Research Center for Children's Health and Diseases, Shijiazhuang, China.
Papers in Europe PMC - 07Zhang L4 papers · 2025
Department of Respirology, Hebei children's Hospital, Hebei Clinical Medicine Research Center for Children's Health and Diseases, Shijiazhuang, China.
Papers in Europe PMC - 08Zhou J4 papers · 2026
Department of Respiratory Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Papers in Europe PMC - 09Chen Y3 papers · 2026
Department of Pulmonary and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China.
Papers in Europe PMC - 10Lee JS3 papers · 2025
Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
5
interventional trials for this specific condition
5 interventional trials matched this specific condition name; none in our sample are currently recruiting. 1,758 trials are registered for pneumonia, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026
5 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 89.2th percentile).
low confidence · 89.2th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
5 interventional trials matched after quoted-phrase search and title/condition post-filter.
No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.
Broader category: pneumonia
1,758
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT07351500·NOT YET RECRUITING·Adaptive RCT of Corticosteroids for Severe Influenza Pneumonia in Adults
Not reviewed·Conditions: Influenza·Matched via name phrase
- NCT07106203·NOT YET RECRUITING·Effect of Pursed-Lip Breathing on Physiological Parameters and Discharge Readiness in Children With Pneumonia
Not reviewed·Conditions: Pneumonia·Matched via name phrase
- NCT06966310·RECRUITING·Awake Prone Positioning of Patients Suffering Community Acquired Pneumonia Requiring Nasal High Flow Therapy
Not reviewed·Conditions: Community-acquired Pneumonia·Matched via name phrase
- NCT07631377·NOT YET RECRUITING·The LalelaLung Study: Digital Stethoscope Clinical Evaluation
Not reviewed·Conditions: Pneumonia · Tuberculosis, Pulmonary · Respiratory Tract Infections · Bronchiolitis·Matched via name phrase
- NCT07206745·RECRUITING·A Study on Integrated Chinese and Western Medicine for Severe Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacterial Infections
Not reviewed·Conditions: Severe Pneumonia Caused by Multidrug-resistant Gram-negative Bacterial Infection·Matched via name phrase
- NCT07237633·RECRUITING·Evaluating the Feasibility of a Piezoelectric Smart Sensor as an Aid to Help Clinicians Screen for the Development of Pneumonia in an At-risk Population
Not reviewed·Conditions: Stroke · End Stage Renal Failure on Dialysis·Matched via name phrase
- NCT04858412·RECRUITING·Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19
Not reviewed·Conditions: Alcoholic Liver Disease · COVID 19 Pneumonia·Matched via name phrase
- NCT07647666·NOT YET RECRUITING·Oropharyngeal Flushing Suction Tube With Laryngoscope for Stroke-Associated Pneumonia
Not reviewed·Conditions: Acute Ischemic Stroke · Stroke-Associated Pneumonia (SAP)·Matched via name phrase
- NCT03527992·RECRUITING·Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia
Not reviewed·Conditions: Pneumonia · Pneumonia, Ventilator-Associated · Length of Stay·Matched via name phrase
- NCT05979545·RECRUITING·EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
Not reviewed·Conditions: Blood Stream Infections · Ventilator Associated Pneumonia · Healthcare Associated Infection · Carbapenem-Resistant Enterobacteriaceae Infection·Matched via name phrase
- NCT07438834·NOT YET RECRUITING·Continuous Sedation vs Daily Sedation Interruption in Ventilated Children
Not reviewed·Conditions: Pneumonia · Respiration Disorders·Matched via name phrase
- NCT07397364·NOT YET RECRUITING·Impact of Nurses' Behavior Change and Evidence-Based Practice Implementation on Quality Indicators in Intensive Care Units in Low- and Middle-Income Countries
Not reviewed·Conditions: Ventilator-Associated Pneumonia (VAP) · Central Line-Associated Bloodstream Infection · Pressure Ulcers (Hospital-acquired Pressure Injuries) · Prolonged Intensive Care Unit Length of Stay·Matched via name phrase
- NCT06310941·NOT YET RECRUITING·Mechanical Insufflation-exsufflation and Hypertonic Saline in Nosocomial Bacterial Respiratory Tract Infection
Not reviewed·Conditions: Nosocomial Infection · Nosocomial Pneumonia · Tracheobronchitis · Mechanical Ventilation Complication·Matched via name phrase
- NCT07270939·NOT YET RECRUITING·Optimizing Enteral Nutrition Regimen for Critically Ill Patients
Not reviewed·Conditions: Critical Illness · Enteral Nutrition · Ventilator Associated Pneumonia · Hyperglycemia·Matched via name phrase
- NCT06554327·RECRUITING·Ventilator Associated Pneumonia Multiplex PCR for Anti-Infective Regimens
Not reviewed·Conditions: Ventilator Associated Pneumonia·Matched via name phrase
Observational and natural-history studies
2 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
None of the matched observational studies is currently listed as recruiting.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 14 · after dedupe 14 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 14 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (14)
- isrctn·ISRCTN22771691·No longer recruiting·A study to investigate if atezolizumab can reduce the size of urothelial cancer before surgery and to determine how the drug works
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15750433·No longer recruiting·A study comparing three vs six cycles of platinum-based chemotherapy before avelumab in advanced bladder cancer
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16358704·No longer recruiting·A study of the safety, pharmacokinetics, and therapeutic activity of cibisatamab in combination with atezolizumab in participants with locally advanced and/or metastatic carcinoembryonic antigen (CEA)-positive solid tumors
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17038127·No longer recruiting·A study investigating if a new medication, bintrafusp alfa, can reduce the size of urothelial carcinoma, a type of bladder cancer, before surgery to remove the bladder
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN51455103·No longer recruiting·A study evaluating the interaction of the body with (pharmacokinetics), clinical activity, and safety of RO6870810 and atezolizumab (PD-L1 Antibody) in participants with advanced ovarian cancer or triple-negative breast cancer
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN95122877·No longer recruiting·Procalcitonin-guided antibiotic therapy and hospitalisation in patients with lower respiratory tract infections: the ProHOSP study
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15842444·Recruiting·Assessing the safety of atezolizumab being directly administered to the bladder in bladder cancer patients undergoing radical cystectomy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN83474167·No longer recruiting·Phase II open-label trial of atezolizumab in patients with urinary tract squamous cell carcinoma
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11595117·No longer recruiting·A study evaluating single-agent inavolisib and inavolisib plus atezolizumab in PIK3CA-mutated cancers
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11965217·No longer recruiting·A trial to assess whether the addition of atezolizumab to current standard treatment for patients with relapsed or refractory Diffuse Large B-Cell Lymphoma, who are not able to have high dose therapy, improves survival outcomes
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN67463316·Recruiting·Is datopotamab deruxtecan plus durvalumab more effective than datopotamab deruxtecan alone at treating patients with metastatic breast cancer?
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11908197·Recruiting·Disitamab vedotin with pembrolizumab vs chemotherapy in previously untreated urothelial cancer expressing HER2
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN62420110·No longer recruiting·A study of selicrelumab (RO7009789) in combination with atezolizumab in participants with locally advanced and/or metastatic solid tumors
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN83971151·No longer recruiting·Public health emergency SOLIDARITY trial of treatments for COVID-19 infection in hospitalized patients
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Cryptogenic organizing pneumonia — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Cryptogenic organizing pneumonia" OR "Bronchiolitis obliterans organizing pneumonia" OR "Organizing Pneumonia" OR "cryptogenic organizing pneumonitis" OR "organising pneumonia"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Cryptogenic organizing pneumonia" OR "Bronchiolitis obliterans organizing pneumonia" OR "Organizing Pneumonia" OR "cryptogenic organizing pneumonitis" OR "organising pneumonia"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 5 interventional · 2 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"pneumonia"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: BOOP; COP
Confidence reasoning
- Preferred label is multi-word and distinctive
- 2 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
- Publication count (12177) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-26T16:58:26.244Z
